Human Milk Oligosaccharides in Infant
Formula Market
Human Milk Oligosaccharides in Infant Formula
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Human Milk Oligosaccharides in Infant Formula Market
Size and Growth
The Human Milk Oligosaccharides (HMO) in Infant Formula market is rapidly expanding, driven by rising demand for advanced nutrition. The market is projected to grow significantly, reaching approximately $XXX million by 2028. Increasing awareness of HMO benefits and regulatory support further enhance market conditions, fostering innovation and competition among key players.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ BASF
◍ Dextra Laboratories
◍ DuPont
◍ Elicityl
◍ Glycom
◍ Glycosyn
◍ Inbiose
◍ Jennewein Biotechnologie
◍ Nestle Health Science
◍ Zuchem
The Human Milk Oligosaccharides (HMO) market in infant formula is competitive, with companies like Abbott and Nestlé Health Science integrating HMOs to enhance nutritional profiles. BASF and DuPont focus on innovative HMO sourcing, while Glycom and Jennewein Biotechnologie specialize in production scalability. Sales figures reflect growth, showcasing demand.
Request Sample Report
Market Segmentation
By Application
◍ Infant Formula
◍ Functional Food & Beverages
◍ Food/Medical Supplements
◍ Other
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
